Not available
Quote | Vascular Biogenics Ltd. (NASDAQ:VBLT)
Last: | $0.156 |
---|---|
Change Percent: | -1.4% |
Open: | $0.1734 |
Close: | $0.156 |
High: | $0.1925 |
Low: | $0.1526 |
Volume: | 5,400,808 |
Last Trade Date Time: | 10/16/2023 03:00:00 am |
News | Vascular Biogenics Ltd. (NASDAQ:VBLT)
Approved Merger with Notable Labs and All Other Proposals Merger Expected to Close and Begin Trading as Combined Company Under the NTBL Ticker on Nasdaq Next Week, Subject to Effectiveness of Approved Israeli Corporate Actions MODI’IN, Israel and NEW YORK, Oct. 12, 2023 (GL...
2023-10-09 13:00:03 ET More on InMode, Nano-X, etc. Full Of Potential Red Flags: Breaking Down Nano-X Imaging Nano-X Imaging: Cash Burn Makes It A Hold InMode: Bullish Support Failed To Materialize War between Israel and Hamas pushes U.S.-traded Israeli stock...
Message Board Posts | Vascular Biogenics Ltd. (NASDAQ:VBLT)
Subject | By | Source | When |
---|---|---|---|
The trading last trade up | midastouch017 | investorshub | 05/10/2023 1:05:05 PM |
Lets go go go go... Up up and away we go. | erik007tc | investorshub | 05/07/2023 1:17:10 PM |
what do you make of this data? | backtoreality | investorshub | 05/07/2023 6:52:41 AM |
Time for a bounce? | ALERTS100%to10000%GAIN | investorshub | 05/06/2023 10:20:37 AM |
MomentumIts now last trade up | Chenteddybear | investorshub | 05/06/2023 6:06:57 AM |
News, Short Squeeze, Breakout and More Instantly...
Vascular Biogenics Ltd. Company Name:
VBLT Stock Symbol:
NASDAQ Market:
Approved Merger with Notable Labs and All Other Proposals Merger Expected to Close and Begin Trading as Combined Company Under the NTBL Ticker on Nasdaq Next Week, Subject to Effectiveness of Approved Israeli Corporate Actions MODI’IN, Israel and NEW YORK, Oct. 12, 2023 (GL...
MODI’IN, Israel and NEW YORK, Oct. 04, 2023 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT) (“VBL”), reminds its shareholders to vote in favor of the previously announced proposed merger (the “Merger”) with Notable Labs (“Notable”) at the annua...
Merger with Notable expected to close in mid-October, subject to shareholder approval Special shareholder meeting scheduled for October 12, 2023 MODI’IN, Israel and NEW YORK, Sept. 06, 2023 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT) (“VBL”), today ann...